Evaluation of a pharmacist-led digital hypertension management program in a tertiary hospital in Singapore
By
Elena Meishan Lee
Xuan Han Koh
Kah Mun Cheong
Qian Hui Khor
Chang Yin Chionh
Joan Khoo
Alicia Seah
Pu En Ow Yong
May 12, 2026
Clinical Scorecard: Assessment of a pharmacist-directed digital program for hypertension management at a tertiary care facility in Singapore
At a Glance
Category Detail
Condition Hypertension Key Mechanisms Pharmacist-led telemonitoring and medication optimization Target Population Adults aged 21 years or older with documented hypertension Care Setting Tertiary hospital outpatient clinics
Key Highlights
Over one in three adults in Singapore has hypertension. Pharmacist-led clinics offer shorter waiting times and timely medication adjustments. Telemonitoring can improve blood pressure control and patient outcomes. The DEMO program utilizes Bluetooth and non-Bluetooth BP monitors for remote monitoring. Participants can exit the program upon achieving target BP or after six months. Guideline-Based Recommendations
Diagnosis
Documented diagnosis of hypertension required for eligibility. Management
Antihypertensive therapy titrated according to ACC/AHA guidelines. Monitoring & Follow-up
BP measurements captured weekly and reviewed during teleconsultations. Risks
Potential self-selection bias due to voluntary digital service participation. Patient & Prescribing Data
Patients enrolled in the DEMO program at Changi General Hospital.
Use of digital tools for continuous monitoring and medication adjustments.
Clinical Best Practices
Implement collaborative physician-pharmacist models for hypertension management. Utilize telehealth for continuous patient engagement and monitoring. Ensure accessibility of digital platforms for patient participation. Related Resources & Content
